Effectiveness of Lactobacillus reuteri DSM 17938 for the Prevention of Nosocomial Diarrhea in Children: A Randomized, Double-blind, Placebo-controlled Trial

Pediatric Infectious Disease Journal

Volumn 35, Issue 2, 2016, Pages 142-145

  Urbańska, Magdalena ^a   Gieruszczak Białek, Dorota ^a   Szymański, Henryk ^b   Szajewska, Hania ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b Department of Paediatrics   (Poland)

Author keywords

hospital; infants; microbiota; pediatrics

Indexed keywords

PROBIOTIC AGENT; ROTAVIRUS VACCINE; PLACEBO;

ABDOMINAL PAIN; ARTICLE; CHILD; CHILD HOSPITALIZATION; CHRONIC DIARRHEA; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; FEBRILE CONVULSION; FECES ANALYSIS; FEMALE; FEVER; FLATULENCE; HOSPITAL INFECTION; HUMAN; INFANT; INFECTION PREVENTION; LACTOBACILLUS REUTERI; LACTOBACILLUS REUTERI DSM 17938; LENGTH OF STAY; LOOSE FECES; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NOSOCOMIAL DIARRHEA; POLAND; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; VACCINATION; CLINICAL TRIAL; CROSS INFECTION; GROWTH, DEVELOPMENT AND AGING; TREATMENT OUTCOME;

CHILD, PRESCHOOL; CROSS INFECTION; DIARRHEA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFANT; LACTOBACILLUS REUTERI; MALE; PLACEBOS; PROBIOTICS; TREATMENT OUTCOME;

EID: 84955416273     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000948     Document Type: Article

References (19)

1. World Health Organisation/Patient Safety. Report on the Burden of Endemic Health Care-associated Infection Worldwide. Geneva, Switzerland: World Health Organization; 2011.
2. Posfay-Barbe KM, Zerr DM, Pittet D. Infection control in paediatrics. Lancet Infect Dis. 2008;8:19-31.
3. World Health Organization (http://www.who.int/en/).
4. WHO Guidelines on Hand Hygiene In Health Care. First Global Patient Safety Challenge Clean Care is Safer Care. Available at: http://whqlibdoc.who.int/publications/2009/9789241597906-eng.pdf. Accessed May 5, 2015.
5. Mrukowicz J, Szajewska H, Vesikari T. Options for the prevention of rotavirus disease other than vaccination. J Pediatr Gastroenterol Nutr. 2008;46 (Suppl 2):S32-S37.
6. Karafillakis E, Hassounah S, Atchison C. Effectiveness and impact of rotavirus vaccines in Europe, 2006-2014. Vaccine. 2015;33:2097-2107.
7. Rosander A, Connolly E, Roos S. Removal of antibiotic resistance genecarrying plasmids from Lactobacillus reuteri ATCC 55730 and characterization of the resulting daughter strain, L. reuteri DSM 17938. Appl Environ Microbiol. 2008;74:6032-6040.
8. Wanke M, Szajewska H. Lack of an effect of Lactobacillus reuteri DSM 17938 in preventing nosocomial diarrhea in children: a randomized, doubleblind, placebo-controlled trial. J Pediatr. 2012;161:40-43.e1.
9. Szajewska H, Urbaska M, Chmielewska A, et al. Meta-analysis: Lactobacillus reuteri strain DSM 17938 (and the original strain ATCC 55730) for treating acute gastroenteritis in children. Benef Microbes. 2014;5:285-293.
10. Francavilla R, Lionetti E, Castellaneta S, et al. Randomised clinical trial: Lactobacillus reuteri DSM 17938 vs. placebo in children with acute diarrhoea - A double-blind study. Aliment Pharmacol Ther. 2012;36:363-369.
11. Szajewska H, Kotowska M, Mrukowicz JZ, et al. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J Pediatr. 2001;138:361-365.
12. Ganczak M, Dmytrzyk-Daniów G, Karakiewicz B, et al. Determinants influencing self-paid vaccination coverage, in 0-5 years old Polish children. Vaccine. 2013;31:5687-5692.
13. Pokorna-Kawak D, Gwiazda E, Mastalerz-Migas A, et al. Rotavirus vaccine coverage in one primary care setting. Family Med Prim Care Rev. 2009;11:458-60.
14. Szajewska H, Wanke M, Patro B. Meta-analysis: the effects of Lactobacillus rhamnosus GG supplementation for the prevention of healthcare-associated diarrhoea in children. Aliment Pharmacol Ther. 2011;34:1079-1087.
15. Saavedra JM, Bauman NA, Oung I, et al. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet. 1994;344:1046-1049.
16. Hojsak I, Toki Pivac V, Moi Pavi A, et al. Bifidobacterium animalis subsp. lactis fails to prevent common infections in hospitalized children: a randomized, double-blind, placebo-controlled study. Am J Clin Nutr. 2015;101:680-684.
17. Penna FGC, Loures BM, Ribas de Carvalho A. Lack of effect of Lactobacillus delbruecki H2B20 in the prevention of diarrhea in children hospitalized for short period. Pediatria (Sao Paulo) 2009; 31:76-80.
18. Gutierrez-Castrellon P, Lopez-Velazquez G, Diaz-Garcia L, et al. Diarrhea in preschool children and Lactobacillus reuteri: a randomized controlled trial. Pediatrics. 2014;133:e904-e909.
19. Agustina R, Kok FJ, van de Rest O, et al. Randomized trial of probiotics and calcium on diarrhea and respiratory tract infections in Indonesian children. Pediatrics. 2012;129:e1155-e1164.